Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)

Autor: Natallia Dziuba, Ian G. Barr, Slobodan Paessler, Lifang Zhang, Michele A. Zacks, Nathaniel S. Linde, Jeanon N. Smith, C. Shane Arnold, Nadezhda E. Yun, J. M. Kilpatrick, Aeron C. Hurt, Michael R. Holbrook
Rok vydání: 2008
Předmět:
Zdroj: Virology. 374(1):198-209
ISSN: 0042-6822
DOI: 10.1016/j.virol.2007.12.029
Popis: The post-exposure therapeutic efficacy of injectable peramivir against highly pathogenic avian influenza type A H5N1 was evaluated in mice and in ferrets. Seventy to eighty percent of the H5N1-infected peramivir-treated mice, and 70% in the oseltamivir treated mice survived the 15-day study period, as compared to 36% in control (vehicle) group. Ferrets were infected intranasally with H5N1 followed by treatment with multiple doses of peramivir. In two of three trials, a statistically significant increase in survival over a 16–18 day period resulted from peramivir treatment, with improved survival of 40–64% in comparison to mock-treated or untreated animals. Injected peramivir mitigates virus-induced disease, reduces infectious virus titers in the lungs and brains and promotes survival in ferrets infected intranasally with this highly neurovirulent isolate. A single intramuscular peramivir injection protected mice against severe disease outcomes following infection with highly pathogenic avian influenza and multi-dose treatment was efficacious in ferrets.
Databáze: OpenAIRE